Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

84 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Synthesis and structure-activity relationships of amide derivatives of (4,4-difluoro-1,2,3,4-tetrahydro-5H-1-benzazepin-5-ylidene)acetic acid as selective arginine vasopressin V2 receptor agonists.
Tsukamoto I, Koshio H, Kuramochi T, Saitoh C, Yanai-Inamura H, Kitada-Nozawa C, Yamamoto E, Yatsu T, Shimada Y, Sakamoto S, Tsukamoto S. Tsukamoto I, et al. Among authors: yatsu t. Bioorg Med Chem. 2009 Apr 15;17(8):3130-41. doi: 10.1016/j.bmc.2009.03.001. Epub 2009 Mar 9. Bioorg Med Chem. 2009. PMID: 19321349
Optimization of (4,4-difluoro-1,2,3,4-tetrahydro-5H-1-benzazepine-5-ylidene)acetamide derivatives as arginine vasopressin V2 receptor agonists and discussion of their binding modes.
Tsukamoto I, Koshio H, Orita M, Saitoh C, Yanai-Inamura H, Kitada-Nozawa C, Yamamoto E, Yatsu T, Sakamoto S, Tsukamoto S. Tsukamoto I, et al. Among authors: yatsu t. Bioorg Med Chem. 2009 Dec 15;17(24):8161-7. doi: 10.1016/j.bmc.2009.10.038. Epub 2009 Oct 23. Bioorg Med Chem. 2009. PMID: 19900813
Synthesis and biological activity of novel 4,4-difluorobenzazepine derivatives as non-peptide antagonists of the arginine vasopressin V1A receptor.
Shimada Y, Taniguchi N, Matsuhisa A, Akane H, Kawano N, Suzuki T, Tobe T, Kakefuda A, Yatsu T, Tahara A, Tomura Y, Kusayama T, Wada K, Tsukada J, Orita M, Tsunoda T, Tanaka A. Shimada Y, et al. Among authors: yatsu t. Bioorg Med Chem. 2006 Mar 15;14(6):1827-37. doi: 10.1016/j.bmc.2005.10.035. Epub 2005 Nov 11. Bioorg Med Chem. 2006. PMID: 16290163
Nonpeptide arginine vasopressin antagonists for both V1A and V2 receptors: synthesis and pharmacological properties of 4-(1,4,5,6-tetrahydroimidazo[4,5-d][1]benzoazepine-6-carbonyl)benzanili de derivatives and 4'-(5,6-dihydro-4H-thiazolo[5,4-d][1]benzoazepine-6-carbonyl)benzanilid e derivatives.
Matsuhisa A, Taniguchi N, Koshio H, Yatsu T, Tanaka A. Matsuhisa A, et al. Among authors: yatsu t. Chem Pharm Bull (Tokyo). 2000 Jan;48(1):21-31. doi: 10.1248/cpb.48.21. Chem Pharm Bull (Tokyo). 2000. PMID: 10705470
Highly potent and orally active non-peptide arginine vasopressin antagonists for both V1A and V2 receptors: synthesis and pharmacological properties of 4'-[(4,4-difluoro-5-methylidene-2,3,4,5-tetrahydro-1H-1-benzoazepin-1-y l)carbonyl]-2-phenylbenzanilide derivatives.
Shimada Y, Taniguchi N, Matsuhisa A, Sakamoto K, Yatsu T, Tanaka A. Shimada Y, et al. Among authors: yatsu t. Chem Pharm Bull (Tokyo). 2000 Nov;48(11):1644-51. doi: 10.1248/cpb.48.1644. Chem Pharm Bull (Tokyo). 2000. PMID: 11086891
Preparation of highly potent and selective non-peptide antagonists of the arginine vasopressin V1A receptor by introduction of a 2-ethyl-1H-1-imidazolyl group.
Shimada Y, Akane H, Taniguchi N, Matsuhisa A, Kawano N, Kikuchi K, Yatsu T, Tahara A, Tomura Y, Kusayama T, Wada K, Tsukada J, Tsunoda T, Tanaka A. Shimada Y, et al. Among authors: yatsu t. Chem Pharm Bull (Tokyo). 2005 Jul;53(7):764-9. doi: 10.1248/cpb.53.764. Chem Pharm Bull (Tokyo). 2005. PMID: 15997131 Free article.
84 results